The Pharmacy Collect and lateral flow device (LFD) test kit scheme is closing – what you need to know:

Since the start of the Pharmacy Collect programme Alliance Healthcare has partnered the UKHSA to deliver over 320 million lateral flow device (LFD) test kits to community pharmacy across the UK.

In line with the Government’s Living with Covid Plan and testing for most citizens ceasing at the end of March, we are working with UKHSA to ensure that LFD test kits continue to be evenly distributed in the remaining two weeks and, just as importantly, that the amount of remaining stock after the service closes is minimised.

UKHSAs’ last delivery to Alliance Healthcare UK is Friday 18th March. Alliance Healthcare will continue to deliver LFDs whilst stocks last and up until Friday 25th March.

You will not be able to place a Return for LFD test kits from 18th March, unless it is faulty or damaged. Visit www.alliance-healthcare.co.uk for further details.

Alliance Healthcare UK to enter into a wholesale agreement with Advanced Medical Solutions April 2022

We are pleased to announce that, as of 01 April 2022, Alliance Healthcare UK will become one of the chosen wholesalers to supply Advanced Medical Solutions’ product portfolio to all pharmacies, hospitals and dispensing doctors in the United Kingdom.

To receive Adavanced Medical Solutions’ products from 01 April 2022, you can simply order from Alliance Healthcare in your usual manner. These products will be available on a next day delivery service.

Class 4 Drug Caution In Use - Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder and solvent for suspension for injection

Brancaster Pharma Limited have notified us of an issue relating to the label of the Water for Injections (solvent) packaged in each finished product pack.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-benzylpenicillin-benzathine-1-dot-2-million-iu-and-2-dot-4-million-iu-powder-and-solvent-for-suspension-for-injection-el-22-a-slash-15?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=0932503e-1ef9-44ca-ae54-31760eaacaf9&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information and stock control queries please contact: safety@brancasterpharma.com

Company Led Recall - NETSPOT (Kit for the preparation of gallium Ga 68 dotatate injection) [unlicensed medicine]

Advanced Accelerator Applications is recalling specific batches of this product as a precautionary measure due to an out of specification result that was identified during stability testing.

MHRA drug alert link: 

https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-advanced-accelerator-applications-netspot-kit-for-the-preparation-of-gallium-ga-68-dotatate-injection-unlicensed-medicine-clmr-22-a-slash-02?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=1f3d3fed-4932-4368-813d-6fcf6dd2ef00&utm_content=immediately

Alliance do not stock this product and therefore we are not accepting stock returns.

Company contact for medical enquiries

For more medical information please contact Diane Fogarty: diana.fogarty@novartis.com

Company contact for stock enquiries

For more stock information please contact Jane Farr: jane.farr@novartis.com

Class 4 Drug Caution In Use - Beclometasone dipropionate 50 micrograms/dose Nasal Spray (Various Liveries)

Ayrton Saunders Limited have identified an error relating to the Braille printed on the cartons.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-ayrton-saunders-limited-beclometasone-dipropionate-50-micrograms-slash-dose-nasal-spray-various-liveries-el-22-a-slash-14?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=3cee273e-9974-4dab-91dc-ef9076df844b&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For medical information and stock control queries please contact: Ayrton Saunders Ltd., 9 Arkwright Road, Astmoor Industrial Estate, Runcorn, Cheshire, WA7 1NU or quality@ayrtons.com

Class 4 Drug Caution In Use - Latuda film-coated tablets

CNX Therapeutics Ltd. have notified the MHRA that the batches of Latuda film-coated tablets listed in this notification will be released without EAN barcodes on the cartons.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-cnx-therapeutics-ltd-latuda-film-coated-tablets-el-22-a-slash-13?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=dac1ea2a-e6e3-4479-b1e3-e8b6894509b8&utm_content=immediately

This is a caution in use only we are not accepting stock returns.

Further Information

For more information and medical information contact: medinfo@cnx-therapeutics.com

For stock control queries please contact: supplychain@cnx-therapeutics.com

Important update on operations in Eastern Europe

AmerisourceBergen - 15 March 2022

Leaders at AmerisourceBergen continue to monitor the international response and reaction to Russia’s invasion of Ukraine.

All operations in Ukraine remain suspended to ensure the safety of our team members, partners and customers. AmerisourceBergen will cease new business initiatives in Russia and Belarus while completing support of existing clinical trials and continuing distribution of oncology therapies and other pharmaceutical products.

We will continue to share more information as soon as it is available. Please keep checking this page for further updates. If you have any additional questions, please reach out to your local World Courier representative.

For more information about AmerisourceBergen’s current operations in Eastern Europe, please read this statement from Robert Mauch, Executive Vice President and Group President of AmerisourceBergen.

UPDATE on Chessington CD Deliveries

We are pleased to advise the earlier technical issue resulting in delays to Controlled Drug deliveries from Chessington service centre has now been fully resolved.

All outstanding CD orders will be delivered on Monday morning, there is no need to re-order. Should you have an emergency requirement, please contact Customer Service.

We apologise for the inconvenience caused, and thank you for your cooperation.

AmerisourceBergen and Alliance Healthcare - March 7, 2022

An Alliance Healthcare spokesperson said:

“Our thoughts are with the Ukrainian people whose resilience and fortitude is truly remarkable and inspirational to us all.  As the conflict in Ukraine continues, our priority has been – and will remain – to put the health of all team members and patients first.

Across all businesses within AmerisourceBergen, our team members are working with governments, associations and partners across Europe to understand and respond to the needs identified by Ukrainian authorities and humanitarian organisations, such as the World Health Organisation.

The safety and wellbeing of our eleven Word Courier colleagues in Ukraine is a priority and we provide all necessary support to them. They will remain in our thoughts in the days and weeks ahead.  

In alignment with AmerisourceBergen Foundation’s mission a commitment of $100,000 in grant donations have been deployed to support organizations on the ground in Ukraine to provide care and relief to those impacted by this conflict, including Direct Relief to support their emergency response in and around Ukraine.

The Foundation is also matching employee donations on a 2:1 basis to Direct Relief, International Committee of the Red Cross and the Ukraine Crisis Relief Fund at GlobalGiving. i.e. for every Euro donated by a colleague, the Foundation will donate two. The AB Foundation is committed to support relief efforts surrounding the Ukraine crisis over the long term. This donation is an initial step in these efforts.

Other support from our country businesses include:

• > Romania has initiated projects with Save the Children including providing support for mother and children refugees and a donation of infant formula and baby food along with giving 15,000 euros to hospitals in Ukraine on Romanian border and a further 15,000 euros to assist Ukrainian refugees in Romania.
• > Alloga in the Czech Republic is working with the Ministry of Health and providing vital logistical expertise transporting medical products to the Ukraine.
• > In Lithuania, the team have already worked with the Government to supply vital medicines to Ukraine; and after collaboration with the Lithuanian Ministry of Health and a third party organisation, it is now supplying vital medicines directly to the Lviv Children’s hospital in Ukraine.
• > Norway is making a significant financial donation of over 450,000 NOK ($50,000) to the Red Cross.
• > In Turkey as part of the company’s membership of the American Chamber of Commerce, our team is investigating how it can support with both humanitarian and medical requirements.  
• > Even in markets further away in geographical terms, colleagues, Alphega member pharmacies and partners are collaborating to plan additional support including further product donations.  
• > We take our responsibility to protect the international supply chain, serve our customers and patients, and make timely decisions seriously. As a business we remain 100% committed to ensuring continued supply and access to medicines and essential healthcare products to the communities across our network.

A perspective from Steve Collis, CEO of AmerisourceBergen can be found at: (8) Finding Solace in Insecurity – Reflecting on the Invasion of Ukraine | LinkedIn

Class 2 Recall - Diazepam Rectubes 2.5mg Rectal Solution

Wockhardt UK Ltd are recalling a batch of Diazepam RecTubes 2.5mg Rectal Solution due to an out of specification result for assay during routine stability testing.

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-wockhardt-uk-ltd-diazepam-rectubes-2-dot-5mg-rectal-solution-el-22-a-slash-11?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ebb2ea59-2e04-4d36-ae96-7a763b1bac0f&utm_content=immediately

Further Information

For more information, medical or supply enquiries, please contact: drug.safety@wockhardt.co.uk

For stock control queries, please contact: customer.services@wockhardt.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.